The ACTH test fails to diagnose adrenal insufficiency and augments cytokine production in sepsis.
Summary
In septic mouse models, the ACTH stimulation test erroneously labels most animals as adrenal insufficient, including those with intact stress responses. Moreover, ACTH provokes lethal cytokinemia and increases mortality, indicating the test can be harmful in sepsis and may have confounded prior steroid trial interpretations.
Key Findings
- In septic mice, the ACTH test classified most animals as adrenal insufficient even when adrenal stress responses were intact.
- ACTH stimulation markedly increased inflammatory cytokines to lethal levels and moderately raised mortality.
- Findings indicate fundamental flaws in the ACTH test for diagnosing RAI/CIRCI and suggest it may have confounded prior glucocorticoid trial outcomes.
Clinical Implications
Clinicians should be cautious in using ACTH stimulation to guide steroid therapy in sepsis; alternative, non-provocative biomarkers and functional assessments are needed to identify true corticosteroid insufficiency without amplifying inflammation.
Why It Matters
The study challenges a longstanding diagnostic tool for CIRCI in sepsis and reveals potential iatrogenic harm, prompting a reassessment of patient selection strategies for glucocorticoid therapy.
Limitations
- Preclinical animal data may not fully translate to humans.
- Dosing, timing, and physiological differences limit direct clinical extrapolation.
Future Directions
Develop and validate non-provocative diagnostics for CIRCI in sepsis; observational human studies assessing biomarker-based adrenal function without ACTH; re-analyze steroid trials excluding ACTH-based selection to test benefit in true insufficiency.
Study Information
- Study Type
- Basic/Mechanistic Research
- Research Domain
- Diagnosis
- Evidence Level
- V - Preclinical experimental study in septic mouse models evaluating diagnostic test effects
- Study Design
- OTHER